Fate Therapeutics shares owned by Citadel Advisors
Quarter-by-quarter ownership of Fate Therapeutics (FATE) shares owned by Citadel Advisors
from 13F filings
Historical chart of Citadel Advisors investment in Fate Therapeutics
Tip: Access up to 7 years of quarterly data
All positions including Fate Therapeutics held by Citadel Advisors consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in Fate Therapeutics by Citadel Advisors
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2025-09-30 | $1.1M | 876k | 1.26 |
| 2025-06-30 | $5.2M | 4.6M | 1.12 |
| 2025-03-31 | $3.4M | 4.3M | 0.79 |
| 2024-12-31 | $7.3M | 4.4M | 1.65 |
| 2024-09-30 | $15M | 4.3M | 3.50 |
| 2024-06-30 | $15M | 4.5M | 3.28 |
| 2024-03-31 | $23M | 3.2M | 7.34 |
| 2023-12-31 | $10M | 2.7M | 3.74 |
| 2023-09-30 | $4.3M | 2.0M | 2.12 |
| 2023-06-30 | $11M | 2.3M | 4.76 |
| 2023-03-31 | $9.7M | 1.7M | 5.70 |
| 2022-12-31 | $15M | 1.5M | 10.09 |
| 2022-06-30 | $9.8M | 396k | 24.78 |
| 2022-03-31 | $18M | 463k | 38.77 |
| 2021-12-31 | $14M | 234k | 58.51 |
| 2021-09-30 | $13M | 225k | 59.25 |
| 2021-06-30 | $64M | 737k | 86.78 |
| 2021-03-31 | $78M | 943k | 82.46 |
| 2020-12-31 | $107M | 1.2M | 90.92 |
| 2020-09-30 | $106M | 2.7M | 39.97 |
| 2020-06-30 | $114M | 3.3M | 34.31 |
| 2020-03-31 | $51M | 2.3M | 22.21 |
| 2019-12-31 | $17M | 890k | 19.57 |
| 2019-09-30 | $9.1M | 588k | 15.53 |
| 2019-06-30 | $479k | 24k | 20.30 |
| 2019-03-31 | $16M | 924k | 17.57 |
| 2018-12-31 | $16M | 1.3M | 12.83 |
| 2018-09-30 | $13M | 806k | 16.32 |
| 2018-06-30 | $1.4M | 125k | 11.34 |
| 2017-12-31 | $63k | 10k | 6.08 |
| 2017-03-31 | $63k | 14k | 4.58 |
| 2015-12-31 | $49k | 15k | 3.39 |